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Abstract 
Background 
People living with HIV (PLHIV) are very dependent on the antiretroviral therapy (ART) during their lifetime, 
and CD4 cell count is an indicator of ART effectiveness. The objective of this study is to determine the 
predictors of the immunologic success on PLHIV at Dr. Ramelan Naval Hospital, Surabaya and Sidoarjo 
Regency General Hospital. Methods: This research was conducted on 29 PLHIV at Dr. Ramelan Naval 
Hospital, Surabaya and Sidoarjo Regency General Hospital. All subjects had taken ART for six months. CD4 
count, ART card and questionnaires were used in the study. The data was analysed using multiple linear 
regression with SPSS version 21.0. Results: 92.9% subjects were from the key population aged 20-54 years. 
73.9% subjects were in the second clinical stage of AIDS, 68.9% subjects reported high adherence (≥ 95%) to 
ART, 24.1% subjects were not aware of the risk of getting HIV infection when having sexual intercourse 
without using a condom. The results of the multiple linear regression analysis showed there were six predictors 
of immunologic success: adherence to ART (p = 0.047), clinical stages of AIDS (p = 0.004) and the awareness 
of getting HIV infection when having sexual intercourse without using a condom (p = 0.045). 
Conclusion:Monitoring adherence to ART, clinical condition and condom use were very important to achieve 
immunologic success. 
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1. Introduction 
As of 2012, it was estimated that HIV prevalence on Indonesian adults aged 15-45 years was 0.4%. However, 
Indonesia is a country in SEARO with increase rate of HIV new cases, in contrast with other countries which 
had stable or decrease rate. (1) The mortality rate of PLHIV in developing countries is higher than that in 
developed countries due to delays in diagnosis, delays in the provision of ART, lack of knowledge, stigma, 
discrimination, and lack of access to health services. (2,3) 
Until now PLHIV are dependent on ART, as it suppresses HIV replication, (4) thus improving health and 
reduce mortality of people living with HIV, (3,5,6) improving quality of life, (7,8) and reducing the risk of HIV 
transmission through sexual intercourse. (9,10) Care and treatment services for 
PLHIV in Indonesia has the biggest proportion in the national HIV and AIDS strategy and action plan 
2010-2014, between 55% and 60% of the total funding that is equivalent to US$1.1 billion. (11) Despite the 
funding, Indonesia was among 30 countries where 90% of PLHIV had unmet need of ART. (12) 
In Indonesia ART are given to PLHIV who met the criteria written in the National guideline for clinical 
management of HIV and antiretroviral therapy in adults 2011 (Pedoman nasional tatalaksana klinis HIV dan 
terapi antiretroviral pada orang dewasa tahun 2011). First-line ART consists of a combination of two nucleoside 
reverse transcriptase inhibitor (NRTI) and one non nucleoside reverse transcriptase inhibitor (NNRTI). 
Immunologic (CD4 count), virologic (viral load) and clinical condition are indicators of the success or failure of 
therapy. (13) It is therefore necessary to determine predictors of immunologic success on PLHIV at hospitals that 
provide care and treatment services. 
 
2. Methods 
2.1 Research Design 
This cross-sectional study was conducted on 29 PLHIV at Dr. Ramelan Naval Hospital, Surabaya and Sidoarjo 
Regency General Hospital from September to October 2014. This research used quantitative methods to measure 
clinical condition, absolute CD4 cell count, and quality of life using WHO-QoLBREF questionnaire. 
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2.2 Research Subjects 
Included in the study were PLHIV aged 17 years and over, met the eligibility criteria for receiving ART in the 
prevous six months, had been taking ART for six months, voluntarily agreed to participate in the study and 
signed informed consent, were not taking other medications or supplements except those prescribed by Dr. 
Ramelan Naval Hospital, Surabaya and Sidoarjo Regency General Hospital. 
 
2.3 Data Collection 
The absolute CD4 cell count was measured using BD FACSCalibur flow cytometer, liver function tests and 
routine haematological tests were measured using Dimension® RxL® Max, Siemens at the Pathology Clinic 
Laboratory, Dr. Soetomo General Hospital, Surabaya. ART card, demographic questionnaire and Sarason’s 
Social Support Questionnaire (SSQ) were used to collect data from the research sujects. 
 
2.4 Data Analysis 
SSQ consisted of 27 items designed to measure perceptions of social support and satisfaction with that social 
support. (14) The score of social support was then categorized into six groups: poor (<128.996 point), fair 
(128.996-152.996), and good (>152.996). There was only one subject at the clinical stage 4 of AIDS, therefore 
clinical stage 3-4 was categorized into one group. 
Normality and correlation tests were used in the analysis. Multiple linear regression was used to 
determine predictors of immunologic success using SPSS version 21.0. 
 
2.4 Ethical Clearance 
The research ethics approvals were obtained from the Human Research Ethics Committee at Hang Tuah 
University, Dr. Ramelan Naval Hospital Surabaya and Sidoarjo Regency General Hospital. 
 
3. Results 
Based on the Table 1, it was showed that majority (75.9%) of our research subjects were males; 48.3% 
completed 12 years education; 79.3% were on the second clinical stage of AIDS (13); 96.5% were from key 
population; 75.9% reported that they were aware of getting HIV infection while having sex without using a 
condom; 65.5% had good knowledge of HIV and AIDS (the cause, transmission and prevention); 69.0% had fair 
and good support from family, friends, NGO or health care staff; 79.3% always use a condom after being 
diagnosed with HIV infection. 
The mean age of our research subjects was 32.2 years (SD 9.37); and the means of absolute CD4 cell 
count before and after six months of ART were 207.3 cells / mm3 and 266.4 cells / mm3, respectively (Table 2). 
The absolute CD4 cell count after six months of ART showed normal distribution with Shapiro-Wilk 
test (p = 0.936). The absolute CD4 cell count after six months was used as a dependent variable and factors in 
the Table 1 were used as independent variables in a multiple linear regression. 
The adjusted R2 of the final model was 0.673, meaning that the linear regression explained 67.3% of the 
variance in the data. The Durbin-Watson d = 1.714, which was between the critical values of 1.5 < d < 2.5 and 
therefore it was assumed that there was no first order linear auto-correlation in the multiple linear regression 
data. The F-ratio in the ANOVA test showed F = 3.698, p = 0.008, meaning that there was a linear relationship 
between the variables in the model or the independent variables statistically significantly predicted the dependent 
variable. As the Goldfeld-Quandt test was not supported in SPSS, therefore checking the homoscedasticity and 
normality of residuals was conducted by using the Q-Q-Plot of z*pred and z*presid. The plot indicated that in 
the multiple linear regression analysis there was no tendency in the error terms. If that happened, the graph 
would look like a staircase. Moreover, there was no multicollinearity in the multiple linear regression, which was 
showed by tolerance > 0.1 and variance inflation factor (VIF) < 10 for all variables (Table 3). 
Based on the significance (p) of each independent variable in the multiple linear regression in the Table 
3, it was obvious that clinical stages of AIDS, awareness of HIV risk while having sex without using a condom 
and adherence to ART were significant predictors of immunologic success (The absolute CD4 cell count after 
six months of ART). 
Table 3 also showed the unstandardized coefficients, which indicated how much the dependent variable 
varied with an independent variable when all other independent variables were held constant. It was shown that 
subjects with clinical stage 3-4 of AIDS decreased the mean of the absolute CD4 cell count after six months of 
ART by 122.823 cells/mm3 (p = 0.004, 95% CI -202.145, -43.502), compared to that of the subjects with clinical 
stage 2 of AIDS. It was also shown that subjects who were aware of getting HIV infection while having sex 
without using a condom (self-perceived risk) increased the mean of the absolute CD4 cell count after six months 
of ART by 96.071 cells/mm3 (p = 0.045, 95% CI 2.189, 189.952), compared to that of the subjects who were not 
aware of the risk. The last, subjects with good adherence to ART increased the mean of the absolute CD4 cell 
count after six months of ART by 98.607 cells/mm3 (p = 0.047, 95% CI 1.581, 195.634), compared to that of the 
Journal of Health, Medicine and Nursing                                                                                                                                          www.iiste.org 
ISSN 2422-8419     An International Peer-reviewed Journal 
Vol.17, 2015     Special Issue for International Conference of Medical and Health Sciences 2015 
 
109 
Presented in the International Conference of Medical and Health Sciences 2015 
Yogyakarta, September 1st-4th, 2015 
subjects with poor adherence to ART. 
 
4. Discussion 
HIV primarily targets CD4+ T-lymphocytes, and studies have shown that during primary HIV infection, HIV 
viral replication in CD4+ T-lymphocytes results in significant drop of CD4+ T-lymphocyte and an 
accompanying nonspecific immune activation. (15) Subsequent CD4 counts recover after a few months to values 
within the normal range, though pre-infection values are rarely reached. During the progressive course of HIV 
infection a gradual decrease of CD4 T cells is observed. The risk for AIDS-defining illnesses increases with 
time when CD4 T cells decrease below 200. Given the central role of CD4+ T-lymphocytes in HIV 
pathogenesis, CD4+ T-lymphocyte determination during the course of HIV infection is one of the most reliable 
predictors of prognosis for AIDS-defining illnesses. (16, 17) 
To evaluate the success or failure of ART, CD4 count that was taken before PLHIV start ART should 
be compared with the count after six months of therapy. The possibility of failure of therapy typically had 
immunologic patterns as follows: persistent CD4 levels below 100 cells/mm3, CD4 count fell to the baseline or 
below, CD4 count was 50% of the highest level ever achieved for therapy. (13) 
Overall, the mean of CD4 count before ART of all subjects in this study was 207.3 cells/mm3 (SD 
84.2), and it increased to 266.4 cells/mm3 (SD 108.7) after six months of ART. 
In this study adherence to ART was reviewed using the ART card that was brought home by the 
subjects. This was in accordance with a study conducted in 1982 PLHIV who received ART in nine countries in 
southern Africa. This study evaluated adherence to antiretroviral therapy based on the record on the drug card 
and connect it with the effectiveness of antiretroviral based on examination of the absolute CD4 cell count and 
the number of HIV RNA (viral load). The study concluded that the use of ART card to review adherence to ART 
was an accurate measurement, and compliance with therapy was a predictor of success of antiretroviral therapy. 
(18) 
However, a study conducted by Smith et al (2006) indicated that adherence to therapy was not enough 
to be judged based on the percentage of 95% or how many missed dose is not taken, but must be taken into 
account to timekeeping (hours) taking antiretroviral drugs. The study reported that the dose limit of forgotten 
taking medicine but still be tolerable depended on the type of antiretroviral drugs. If the drugs are oblivious 
taken exceeds the threshold, then the blood levels will drop, allowing the occurrence of resistance. For example, 
people with HIV should not be delayed more than 16 hours to take Zalcitabine, but a person with HIV could still 
miss up to 40 tablets (20 days) for taking Nevirapine. However, PLHIV who missed taking the medicine must 
demonstrate compliance up to 99% during the following days to prevent resistance. (19) 
Besides having a role as a predictor of success of ART, adherence to therapy was also associated with 
HIV transmission. Research conducted on 226 male PLHIV in Atlanta, US, reported that people with HIV who 
did not adhere to ART reported that they had more sexual partners and anal sexual intercourse without using a 
condom. People with HIV who do not adhere to this therapy believe that if they are taking antiretroviral drugs 
then they are protected, so they did not need to use a condom during sexual intercourse because they would be 
less likely to transmit HIV. (4) 
A prospective cohort study conducted for 24 months in 416 PLHIV who received ART in Cambodia 
reported that advanced stage of AIDS and low CD4 counts at the beginning of therapy increased the AIDS 
mortality in the first year of ART. This was due to delays in diagnosis and the provision of antiretroviral therapy, 
the difficulty of providing management of opportunistic infections, immune recovery syndrome, or poor 
nutritional status. (20) 
A cross-sectional study conducted on 3,831 men and 3,986 women aged 15-24 years in Mozambique, 
Africa, reported that men and women who were aware of the risk of HIV infection when having sex without 
condoms were significantly associated with the prevalence of condom use during intercourse (30% in males and 
16% for women) compared with the prevalence of condom use among male respondents (14%) and women (6%) 
who were not aware of their risk for HIV infection. Therefore, awareness of the risk of HIV infection might be a 
preventive factor for getting HIV infection. (21) 
A research conducted in South Africa found that male respondents who were aware of the risk 
of HIV infection when having sexual intercourse without using a condom showed higher adherence to 
ART compared to men who were not aware of the risk of HIV infection. (22) So in other study, 
awareness of the risk of HIV infection was not an independent predictor, but it was the moderator of the 
effectiveness of ART. 
The small number of subjects was a limitation of this study. It was quite difficult to find a newly-
infected HIV adult who met the inclusion criteria but not met the exclusion criteria in both Dr. Ramelan Naval 
Hospital and Sidoarjo Regency General Hospital. Therefore, researcher had a collaboration with NGO that 
assisted PLHIV and five Community Health Centers who provide VCT service. The future study should be 
conducted on the larger sample size and should use a cohort or clinical trial design. 
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5. Conclusion 
There were six predictors of the immunologic success (CD4 count after six months of therapy): adherence to 
ART, which had the highest impact on CD4 count after six months of ART (beta = 0.427), awareness of HIV 
risk while having sex without using a condom (beta = 0.385) and clinical stage of AIDS (beta = - 0.578) . 
Accordingly, the six factors had to be carefully monitored to achieve immunologic success of ART. 
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Table 1. Characteristics of research subjects 
 Characteristics n % 
    
 Sex   
 Males 22 75.9 
 Females 7 24.1 
 Education   
 Elementary school 6 20.7 
 Junior high school 6 20.7 
 Senior high school 14 48.3 
 College / university 3 10.3 
 Clinical stages of AIDS   
 2 23 79.3 
 3 - 4 6 20.7 
 Key population   
 No 1 3.5 
 Sex workers 6 20.7 
 High risk men 9 31.0 
 Man who have sex with man 9 31.0 
 Transverstite 4 13.8 
 Self-perceived risk of HIV infection while having sex without a condom  
 Yes 22 75.9 
 No 7 24.1 
 Knowledge about HIV and AIDS   
 Good 19 65.5 
 Poor 10 34.5 
 Score of social support   
 Poor (<128,996 point) 9 31.0 
 Fair (128,996-152,996 point) 10 34.5 
 Good (>152.996 point) 10 34.5 
 Adherence to ART   
 Good (≥ 95%) 20 69.0 
 Poor (< 95%) 9 31.0 
 Condom use   
 Always 23 79.3 
 Sometimes - rarely 6 20.7 
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Table 2. Age and laboratory test results 
 
 Age & laboratory tests mean SD 
    
 Age 32.2 9.37 
 CD4 count before ART 207.3 84.2 
 CD4 count after six months of ART 266.4 108.7 
    
 
 
Table 3. The coefficients table of the multiple linear regression 
 
 Unstandardized Standardized   
95% CI for B 
  
Model Coefficients 
 
Coefficient t Sig 
  
    
 B SE Beta   Lower Upper  
         
(Constant) 322.846 165.726  1.948 0.067 -25.332 671.025  
Knowledge 24.512 51.444 0.113 0.476 0.639 -83.567 132.591  
SSQ 1.159 20.993 0.009 0.055 0.957 -42.946 45.265  
Adherence 98.607 46.183 0.427 2.135 0.047 1.581 195.634  
Sexual practice -49.858 59.957 -0.189 -0.832 0.417 -175.823 76.108  
Sex -23.274 81.588 -0.093 -0.285 0.779 -194.683 148.135  
Level of education -26.669 19.009 -0.233 -1.403 0.178 -66.605 13.268  
AIDS clinical stage -122.823 37.756 -0.578 -3.253 0.004 -202.145 -43.502  
Self-perceived risk 96.071 44.686 0.385 2.150 0.045 2.189 189.952  
Age 1.339 2.553 0.115 0.525 0.606 -4.025 6.703  
Type of key population 37.581 32.604 0.371 1.153 0.264 -30.918 106.080  
         
 
 
 
 
  
